A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants
A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants
NCT ID: NCT05371652 Phase: PHASE3 Status: COMPLETED Enrollment: 241 Completion: 2024-02-06
Conditions
Acute Migraine
Interventions
Rimegepant 75mg Orally Disintegrating Tablets (ODT)
Summary
This trial is to evaluate the long-term safety and tolerability of Rimegepant 75mg ODT in Chinese subjects with migraine
Primary Outcome
Treatment Safety Period: Number of Participants With Treatment Emergent Adverse Events (TEAEs)